Compare BRX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRX | BRKR |
|---|---|---|
| Founded | 2011 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.0B |
| IPO Year | 2013 | 2000 |
| Metric | BRX | BRKR |
|---|---|---|
| Price | $25.30 | $46.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $30.08 | ★ $45.10 |
| AVG Volume (30 Days) | ★ 2.4M | 2.3M |
| Earning Date | 10-27-2025 | 11-03-2025 |
| Dividend Yield | ★ 4.88% | 0.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | $1,346,289,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $7.62 | $3.61 |
| Revenue Next Year | $4.41 | $1.23 |
| P/E Ratio | $23.35 | ★ N/A |
| Revenue Growth | 5.75 | ★ 6.10 |
| 52 Week Low | $22.29 | $28.53 |
| 52 Week High | $29.99 | $64.64 |
| Indicator | BRX | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 60.53 |
| Support Level | $24.66 | $44.96 |
| Resistance Level | $26.61 | $48.84 |
| Average True Range (ATR) | 0.40 | 1.93 |
| MACD | -0.06 | -0.39 |
| Stochastic Oscillator | 32.74 | 56.79 |
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.